COVID-19 LEGAL RESOURCE GUIDE

Explore our thought leadership on important issues and trends.

Show Filters
See Related Results In:

Perspectives

  • Media Mentions
    Feb. 02, 2024
    Kramer Levin Centripetal Trial Team Named “Runners-up” in Litigation Daily’s Litigator of the Week
  • Defining Matters
    Feb. 01, 2024
    Kramer Levin Secures $151.5M Judgment for Centripetal in Cybersecurity Patent Case
  • Bio Law Blog
    Sept. 19, 2023
    10x Genomics and Stanford’s Genomic Patents Determined Patent Eligible
  • Defining Matters
    Aug. 16, 2022
    Federal Circuit Rules in Favor of Kramer Levin Client Centripetal, Blocking Challenge by Palo Alto Networks on Constitutionality of PTAB Refusal to Have Denials Reviewed by the Director
  • Announcements
    July 27, 2022
    Hannah Lee and William Trunk Named to Benchmark Litigation’s 40 and Under List for 2022
  • Articles
    Jan. 07, 2022
    Milk Vitamin Patents Surprisingly Soured By Section 101
  • Bio Law Blog
    Nov. 23, 2021
    Northern District of California Dismisses Challenge to PTAB’s Fintiv Factors
  • Bio Law Blog
    Nov. 16, 2021
    ChromaDex Milk Vitamin Formulation Patents Soured by Section 101
  • Bio Law Blog
    Nov. 09, 2021
    United States Calls for Supreme Court to Deny Petition for Certiorari Challenging Fintiv Factors

Events

  • Speaking Engagement
    Oct. 26, 2023
    CenterForce’s Diversity In IP & Tech Summit
  • Speaking Engagement
    June 28, 2022
    American Conference Institute’s Biosimilars & Innovator Biologics 2022
  • Speaking Engagement
    June 15, 2022
    CenterForce’s Women & Diversity IP
  • Speaking Engagement
    June 03, 2021
    CenterForce’s Women in Law & IP
  • Seminar
    May 19, 2021
    Kramer Levin Webinar: IPRs in 2021 — Key Strategies in a Changed Environment
  • Speaking Engagement
    July 18, 2019
    Medical Device and Life Sciences Patent Litigation in 2019: Subject Matter Eligibility Lessons from Recent Federal Court Decisions